Health and Healthcare Systems

Bill Gates: How HIV/AIDS prepared us to tackle COVID-19

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, attends a news conference as the foundation teams up with the Japan Sports Agency and Tokyo 2020 to promote the Sustainable Development Goals in conjunction with the Olympics, in Tokyo, Japan, November 9, 2018.   REUTERS/Toru Hanai - RC1672C4FB90

Bill Gates has attributed halving HIV infections to the efforts of the Global Fund. Image: REUTERS/Toru Hanai

Harry Kretchmer
Senior Writer, Forum Agenda

Listen to the article

  • Billionaire philanthropist Bill Gates says he is optimistic about beating coronavirus.
  • He told a global AIDS conference that HIV/AIDS had shown how drugs could be made available fairly.
  • He’s warning against poorer countries missing out if drug companies put profits first.
  • The World Health Organization says more than 20 vaccines are undergoing clinical trials.

Around 2 million people a year used to die from HIV/AIDS. Now that figure has more than halved. So what changed?

Bill Gates is clear: the Global Fund – a worldwide philanthropic effort that spends more than $4 billion a year on fighting AIDS, as well as tuberculosis and malaria – was set up.

Have you read?

It’s why Gates, the co-chair of the Bill & Melinda Gates Foundation, told an International AIDS Society conference that he “remains optimistic” that COVID-19 can be defeated – because there is already a successful model for getting on top of pandemics.

However, Gates warns against letting vaccines go to “the highest bidder”, an outcome he says will cause a “longer, more unjust, deadlier pandemic”.

Deaths from HIV/AIDS, by age, world 1990 to 2017.
The fight against HIV/AIDS is proving successful in many countries. Image: Our World in Data

Benefits for AIDS treatments

Bill Gates thinks lessons from the AIDS fight can help defeat COVID-19, in particular teaching us about building “large, fair, global distribution systems”. But he says AIDS treatment programmes can actually benefit too.

“Better diagnostic tools are being developed to help identify these [coronavirus] infections. Investments are being made in libraries of antiviral drugs. Also we’re making great progress on vaccines.”

Loading...

More than 20 vaccines are currently undergoing clinical trials according to the World Health Organization (WHO), with well-advanced studies in the UK and US showing encouraging results.

“These platforms won’t just be useful against this particular virus,” Gates says. “They will also help us specifically for HIV.”

Discover

What is the World Economic Forum doing to manage emerging risks from COVID-19?

Grounds for caution

Yet Gates doesn’t downplay the challenges that the global vaccination movement faces – particular from disruption to existing programmes.

Globally, around 20 coronavirus vaccines are at the clinical trial stage.
Globally, around 20 coronavirus vaccines are at the clinical trial stage. Image: GAVI

In recent months, UNICEF has warned that more than 117 million children globally could miss out on measles vaccinations due to the suspension of immunization programmes. Meanwhile, the WHO cautions that malaria deaths in sub-Saharan Africa could double to 769,000.

And then there’s money. “If we just let drugs and vaccines go to the highest bidder, instead of to the people and the places where they are most needed, we’ll have a longer, more unjust, deadlier pandemic,” Gates says.

Loading...

“We need leaders to make these hard decisions about distributing based on equity, not just on market-driven factors.”

As pharmaceutical companies race to develop successful vaccines, negotiations around pricing and intellectual property rights are likely to remain highly sensitive and contested areas.

But Gates’ overall message to AIDS campaigners – and the wider world – is one of hope. “The world has come together. Specifically, you have done it before.”

Loading...
Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Global Health

Share:
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

What’s the difference between carbon negative and carbon neutral?

Emma Charlton

November 29, 2024

How to transform lung cancer outcomes in low- and middle-income countries

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum